Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.48 USD | -2.40% | +1.05% | +175.95% |
02:21pm | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
09/05 | Q32 Bio Inc. Provides Corporate Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.95% | 360M | |
+9.46% | 115B | |
+12.78% | 107B | |
-13.55% | 22.31B | |
-3.46% | 21.6B | |
-4.84% | 18.23B | |
-38.57% | 17.62B | |
+7.65% | 14.26B | |
+35.04% | 12.37B | |
-26.45% | 8.28B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Trims Homology Medicines' Price Target to $14 From $15, Reiterates Buy Rating